Safety and Tolerability of BRAF Inhibitor and BRAF Inhibitor-Based Combination Therapy in Chinese Patients With Advanced Melanoma: A Real World Study

The toxicity spectrum between Chinese and Caucasian patients with melanoma who were treated with BRAF inhibitors (BRAFi) may differ. The purpose of the present study was to assess the safety and tolerability of BRAFi and BRAFi-based combination therapies [MEK inhibitors (MEKi) or anti-programmed dea...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xing, Li, Jing-jing, Ding, Ya, Li, Dan-dan, Wen, Xi-zhi, Weng, De-sheng, Wang, Jiu-hong, Jiang, Hang, Zhang, Xiao-shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047100/
https://www.ncbi.nlm.nih.gov/pubmed/33868987
http://dx.doi.org/10.3389/fonc.2021.582676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047100/
https://www.ncbi.nlm.nih.gov/pubmed/33868987
http://dx.doi.org/10.3389/fonc.2021.582676

Ejemplares similares